BL-5040

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBL-5040
Drug Alias Nameleptin antagonist (BioLineRx)leptin antagonist (BioLineRx)leptin antagonist (BioLineRx)BL-5040
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLeptin receptor antagonists
TargetsLeptin receptor
Therapy Area/IndicationsFeeding and Eating DisordersCachexiaInflammation +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Hebrew University Of Jerusalem
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx LtdTel-Aviv Sourasky Medical CenterThe Hebrew University Of Jerusalem
Active IndicationsN/A
Inactive IndicationsFeeding and Eating DisordersCachexiaInflammation +[4] 

Other Information

ATC CodeN/A
Related LinksN/A